From Surf Wiki (app.surf) — the open knowledge base

Semaglutide

Semaglutide is an anti-diabetic medication used for the treatment of type 2 diabetes, and an anti-obesity medication used for long-term weight management and to reduce the risk of major adverse cardiovascular events. It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain. It can be administered by subcutaneous injection or taken orally. It is sold by Novo Nordisk under the brand names Ozempic and Rybelsus for diabetes, and under the brand name Wegovy for weight management, weight loss, and the treatment of metabolic-associated steatohepatitis (nonalcoholic steatohepatitis).

Rendering article…

pages-using-the-phonos-extensionpages-with-non-numeric-formatnum-argumentssource-attributioncs1-french-language-sources-frarticles-with-short-description
Content sourced from original.

This content may have been generated or modified by AI, and may be sourced from third parties. CloudSurf Software LLC makes no warranties as to its accuracy, completeness, or reliability, and accepts no liability for it. Always verify important information against primary sources.

Report